Literature DB >> 15324706

Central nervous system involvement in functional gastrointestinal disorders.

Lukas Van Oudenhove1, Koen Demyttenaere, Jan Tack, Qasim Aziz.   

Abstract

Although functional gastrointestinal disorders (FGID) are common, their pathophysiology remains incompletely understood. It is generally accepted that dysfunction of the bidirectional pathways between the gastrointestinal tract and the central nervous system (the 'brain-gut axis') at any level can cause FGID symptoms. In this review article, we focus on the role of the central nervous system in the brain-gut axis. First, we describe the functional anatomy of the brain-gut axis. Second, we focus on the results from brain-imaging studies both in healthy volunteers and in FGID patients. These new investigational techniques made identification of brain regions critically involved in processing of visceral afferent information possible. Differences in central nervous system response to visceral stimuli between controls and FGID patients will be highlighted. Third, we will address the issue of high comorbidity with psychiatric disorders. Some hypotheses about common pathophysiological substrates will be discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15324706     DOI: 10.1016/j.bpg.2004.04.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  47 in total

Review 1.  Gut microbial communities modulating brain development and function.

Authors:  Maha Al-Asmakh; Farhana Anuar; Fahad Zadjali; Joseph Rafter; Sven Pettersson
Journal:  Gut Microbes       Date:  2012-06-29

Review 2.  Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome.

Authors:  Nicola de Bortoli; Irene Martinucci; Massimo Bellini; Edoardo Savarino; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

4.  Excessive coupling of the salience network with intrinsic neurocognitive brain networks during rectal distension in adolescents with irritable bowel syndrome: a preliminary report.

Authors:  X Liu; A Silverman; M Kern; B D Ward; S-J Li; R Shaker; M R Sood
Journal:  Neurogastroenterol Motil       Date:  2015-10-14       Impact factor: 3.598

5.  Autonomic function at rest and in response to emotional and rectal stimuli in women with irritable bowel syndrome.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  Vagal afferent fibres determine the oxytocin-induced modulation of gastric tone.

Authors:  Gregory M Holmes; Kirsteen N Browning; Tanja Babic; Samuel R Fortna; F Holly Coleman; R Alberto Travagli
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

7.  Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome.

Authors:  Gerard Clarke; Peter Fitzgerald; Alan A Hennessy; Eugene M Cassidy; Eamonn M M Quigley; Paul Ross; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

8.  A case of treatment refractory hyperemesis gravidarum in a patient with comorbid anxiety, treated successfully with adjunctive gabapentin: a review and the potential role of neurogastroentereology in understanding its pathogenesis and treatment.

Authors:  David R Spiegel; Kathryn Webb
Journal:  Innov Clin Neurosci       Date:  2012-11

9.  The pathways of interoceptive awareness.

Authors:  Sahib S Khalsa; David Rudrauf; Justin S Feinstein; Daniel Tranel
Journal:  Nat Neurosci       Date:  2009-11-01       Impact factor: 24.884

10.  Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Gastroenterol Res Pract       Date:  2009-09-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.